ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.
Founded
2014
Revenue
$2.5M - $5.0M
Funding
$108.8M
View similar companies
Similar Companies
recyclage des déchets Marseille
AZ Débarras Marseille : Maison - Appartement - Cave - Garage
15-25 Employees
recyclage des déchets Marseille
Agence de collecte des déchets Silim-Veolia
15-25 Employees
recyclage des déchets Marseille
Agence de collecte des déchets industriels - Veolia
15-25 Employees
recyclage des déchets Marseille
Agence de collecte des déchets ménagers - Veolia-BRONZO
15-25 Employees
Qualify this Company in
minutes
While other tools waste time, we help you qualify better-fit companies in minutes, so your pipeline stays healthy, your team stays productive, and your deals move faster.
Start 7-Day Free Trial
